These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25933201)

  • 1. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial.
    de Santana RB; de Santana CM
    J Clin Periodontol; 2015 Jul; 42(7):658-65. PubMed ID: 25933201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
    Gamal AY; Abdel-Ghaffar KA; Iacono VJ
    J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrabony defects, open-flap debridement, and decortication: a randomized clinical trial.
    Crea A; Deli G; Littarru C; Lajolo C; Orgeas GV; Tatakis DN
    J Periodontol; 2014 Jan; 85(1):34-42. PubMed ID: 23537123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
    Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
    J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.
    Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mamajiwala BS
    Clin Oral Investig; 2021 Sep; 25(9):5257-5271. PubMed ID: 33598778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intraosseous defects with bioabsorbable barriers alone or in combination with decalcified freeze-dried bone allograft: a randomized clinical trial.
    Trejo PM; Weltman R; Caffesse R
    J Periodontol; 2000 Dec; 71(12):1852-61. PubMed ID: 11156042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Rao NS; Agarwal E; Bajaj P; Kumari M; Naik SB
    J Periodontol; 2012 Dec; 83(12):1499-507. PubMed ID: 22348695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
    Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
    J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
    Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
    J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
    Kitamura M; Akamatsu M; Kawanami M; Furuichi Y; Fujii T; Mori M; Kunimatsu K; Shimauchi H; Ogata Y; Yamamoto M; Nakagawa T; Sato S; Ito K; Ogasawara T; Izumi Y; Gomi K; Yamazaki K; Yoshie H; Fukuda M; Noguchi T; Takashiba S; Kurihara H; Nagata T; Hamachi T; Maeda K; Yokota M; Sakagami R; Hara Y; Noguchi K; Furuuchi T; Sasano T; Imai E; Ohmae M; Koizumi H; Watanuki M; Murakami S
    J Bone Miner Res; 2016 Apr; 31(4):806-14. PubMed ID: 26547659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration.
    Stavropoulos A; Windisch P; Gera I; Capsius B; Sculean A; Wikesjö UM
    J Clin Periodontol; 2011 Nov; 38(11):1044-54. PubMed ID: 22092476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of injectable calcium phosphate bone cement grafting and open flap debridement in periodontal intrabony defects: a randomized clinical trial.
    Shirakata Y; Setoguchi T; Machigashira M; Matsuyama T; Furuichi Y; Hasegawa K; Yoshimoto T; Izumi Y
    J Periodontol; 2008 Jan; 79(1):25-32. PubMed ID: 18166089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.